ParkinsonCanadaV1, Main, Exploration, bibRecord, 003A40

Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions

Identifieur interne : 003A40 ( Main/Exploration ); précédent : 003A39; suivant : 003A41

Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions

Auteurs : P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada]

Source :

Alzheimer disease and associated disorders [ 0893-0341 ] ; 1998.

RBID : Pascal:99-0023123

Descripteurs français

Pascal (Inist)
- Démence Alzheimer, Parkinson maladie, Sclérose latérale amyotrophique, Névroglie, Complément, Inflammation, Physiopathologie, Traitement, Homme, Cytokine.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Alzheimer Disease (drug therapy), Alzheimer Disease (immunology), Alzheimer disease, Amyotrophic Lateral Sclerosis (drug therapy), Amyotrophic Lateral Sclerosis (immunology), Amyotrophic lateral sclerosis, Anti-Inflammatory Agents, Non-Steroidal (therapeutic use), Complement, Complement Activation (drug effects), Complement Activation (immunology), Cytokine, Cytokines (physiology), Human, Humans, Indomethacin (therapeutic use), Inflammation, Inflammation Mediators (physiology), Microglia (drug effects), Microglia (immunology), Neurodegenerative Diseases (drug therapy), Neurodegenerative Diseases (immunology), Neuroglia, Neuroglia (drug effects), Neuroglia (immunology), Parkinson Disease (drug therapy), Parkinson Disease (immunology), Parkinson disease, Pathophysiology, Treatment.
MESH :
- chemical , physiology : Cytokines, Inflammation Mediators.
- chemical , therapeutic use : Anti-Inflammatory Agents, Non-Steroidal, Indomethacin.
- drug effects : Complement Activation, Microglia, Neuroglia.
- drug therapy : Alzheimer Disease, Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases, Parkinson Disease.
- immunology : Alzheimer Disease, Amyotrophic Lateral Sclerosis, Complement Activation, Microglia, Neurodegenerative Diseases, Neuroglia, Parkinson Disease.
- Humans.

Affiliations:

Canada

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions</title>
<author><name sortKey="Mcgeer, P L" sort="Mcgeer, P L" uniqKey="Mcgeer P" first="P. L." last="Mcgeer">P. L. Mcgeer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Kinsmen Laboratory of Neurological Research and the Neurodegenerative Disorders Centre, University of British Columbia</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mcgeer, E G" sort="Mcgeer, E G" uniqKey="Mcgeer E" first="E. G." last="Mcgeer">E. G. Mcgeer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Kinsmen Laboratory of Neurological Research and the Neurodegenerative Disorders Centre, University of British Columbia</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, British Columbia</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0023123</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 99-0023123 INIST</idno>
<idno type="RBID">Pascal:99-0023123</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D93</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001130</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000D12</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000D12</idno>
<idno type="wicri:doubleKey">0893-0341:1998:Mcgeer P:glial:cell:reactions</idno>
<idno type="wicri:Area/Main/Merge">004062</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9769023</idno>
<idno type="wicri:Area/PubMed/Corpus">001788</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001788</idno>
<idno type="wicri:Area/PubMed/Curation">001788</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001788</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001788</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001788</idno>
<idno type="wicri:Area/Ncbi/Merge">002664</idno>
<idno type="wicri:Area/Ncbi/Curation">002664</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002664</idno>
<idno type="wicri:doubleKey">0893-0341:1998:Mcgeer P:glial:cell:reactions</idno>
<idno type="wicri:Area/Main/Merge">003E65</idno>
<idno type="wicri:Area/Main/Curation">003A40</idno>
<idno type="wicri:Area/Main/Exploration">003A40</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions</title>
<author><name sortKey="Mcgeer, P L" sort="Mcgeer, P L" uniqKey="Mcgeer P" first="P. L." last="Mcgeer">P. L. Mcgeer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Kinsmen Laboratory of Neurological Research and the Neurodegenerative Disorders Centre, University of British Columbia</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mcgeer, E G" sort="Mcgeer, E G" uniqKey="Mcgeer E" first="E. G." last="Mcgeer">E. G. Mcgeer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Kinsmen Laboratory of Neurological Research and the Neurodegenerative Disorders Centre, University of British Columbia</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver, British Columbia</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Alzheimer disease and associated disorders</title>
<title level="j" type="abbreviated">Alzheimer dis. assoc. disord.</title>
<idno type="ISSN">0893-0341</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Alzheimer disease and associated disorders</title>
<title level="j" type="abbreviated">Alzheimer dis. assoc. disord.</title>
<idno type="ISSN">0893-0341</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer Disease (drug therapy)</term>
<term>Alzheimer Disease (immunology)</term>
<term>Alzheimer disease</term>
<term>Amyotrophic Lateral Sclerosis (drug therapy)</term>
<term>Amyotrophic Lateral Sclerosis (immunology)</term>
<term>Amyotrophic lateral sclerosis</term>
<term>Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)</term>
<term>Complement</term>
<term>Complement Activation (drug effects)</term>
<term>Complement Activation (immunology)</term>
<term>Cytokine</term>
<term>Cytokines (physiology)</term>
<term>Human</term>
<term>Humans</term>
<term>Indomethacin (therapeutic use)</term>
<term>Inflammation</term>
<term>Inflammation Mediators (physiology)</term>
<term>Microglia (drug effects)</term>
<term>Microglia (immunology)</term>
<term>Neurodegenerative Diseases (drug therapy)</term>
<term>Neurodegenerative Diseases (immunology)</term>
<term>Neuroglia</term>
<term>Neuroglia (drug effects)</term>
<term>Neuroglia (immunology)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (immunology)</term>
<term>Parkinson disease</term>
<term>Pathophysiology</term>
<term>Treatment</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Cytokines</term>
<term>Inflammation Mediators</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents, Non-Steroidal</term>
<term>Indomethacin</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Complement Activation</term>
<term>Microglia</term>
<term>Neuroglia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Alzheimer Disease</term>
<term>Amyotrophic Lateral Sclerosis</term>
<term>Neurodegenerative Diseases</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Alzheimer Disease</term>
<term>Amyotrophic Lateral Sclerosis</term>
<term>Complement Activation</term>
<term>Microglia</term>
<term>Neurodegenerative Diseases</term>
<term>Neuroglia</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Démence Alzheimer</term>
<term>Parkinson maladie</term>
<term>Sclérose latérale amyotrophique</term>
<term>Névroglie</term>
<term>Complément</term>
<term>Inflammation</term>
<term>Physiopathologie</term>
<term>Traitement</term>
<term>Homme</term>
<term>Cytokine</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Mcgeer, P L" sort="Mcgeer, P L" uniqKey="Mcgeer P" first="P. L." last="Mcgeer">P. L. Mcgeer</name>
</noRegion>
<name sortKey="Mcgeer, E G" sort="Mcgeer, E G" uniqKey="Mcgeer E" first="E. G." last="Mcgeer">E. G. Mcgeer</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A40 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A40 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:99-0023123
   |texte=   Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions

Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.